Chris Farkas
Analyst · Stifel
Thank you, Dave and Glenn, and good morning, everyone. I'm excited to lead our world-class finance organization and to work with the outstanding leadership team and Board to continue to execute on our long-term goals and deliver sustainable value for our stakeholders. Turning to our first quarter results. I'll begin with a review of our end market sales. Overall, we experienced a 26% increase in sales to our defense markets, 20% of which was organic. Meanwhile, sales to our commercial markets declined 11% as conditions began to worsen late in the quarter due to COVID-19, though the overall sales impact was not material. There are a few items I'd like to highlight on this slide. First, in naval defense, we experienced solid revenue growth on both the CVN-80 and CVN-81 aircraft carrier programs, as both are anticipated to ramp up in 2020, following strong orders in 2019. Shifting to the commercial markets. Sales in the commercial aerospace market were down slightly, reflecting customer production slowdowns and plant closures, which began to impact our performance late in the quarter. This was partially offset by the steady production of actuation equipment on the 737 MAX program. In General Industrial, our performance reflects a combination of market-specific drivers and a general drop in economic activity due to COVID-19. And in industrial vehicles, which includes products serving the on-and-off highway markets, sales were expected to be down, mainly due to reduced demand in the on-highway market. Finally, in our surface technologies business, which is most closely linked to global GDP growth, demand was essentially flat earlier in the quarter, but began to weaken as the quarter progressed. Next, I'll discuss the drivers of our first quarter operating performance, which is a reminder, is presented on an adjusted basis. In the commercial/Industrial segment, our results principally reflect higher sales of actuation products as well as the benefits of our proactive cost containment initiatives implemented to mitigate the effects of COVID-19. Partially offsetting that improvement was unfavorable absorption on lower industrial vehicle sales. In the Defense segment, adjusted operating income increased 49%, while adjusted operating margin improved 320 basis points. Although not shown on the slide, organic operating income increased 38% on a 13% increase in organic revenue. This performance reflects favorable absorption on strong defense electronics revenues, a $2 million gain on the sale of a product line, which was partially offset by a $1 million increase in research and development. In the Power segment, our results reflect favorable absorption on solid naval defense revenues. However, more than offsetting that improvement was unfavorable absorption on reduced power generation sales, primarily due to lower international aftermarket sales as several prior year projects did not recur. Next, I'll discuss our 2020 financial outlook. Although we've elected to suspend our full year guidance at this time, I'd like to provide the framework for some of our assumptions regarding sales and profitability. In our defense markets, we maintain a positive outlook for growth in 2020, particularly within naval defense. This optimism reflects our solid backlog following very strong orders in 2019, the contribution from the 901D acquisition and our position as a premier supplier of nuclear propulsion equipment for the navy's most critical programs. Further, we have strong visibility and anticipate higher naval defense orders on aircraft carriers and submarines in the second quarter. Turning to our commercial markets, where the onset of COVID-19 has provided numerous challenges. As we enter the second quarter, we expect significant headwinds, particularly in our commercial aerospace and general industrial markets. In commercial aerospace, I'll begin by putting our sales mix into context where commercial OEM customers represent nearly 90% of our sales with the remainder tied to aftermarket. As expected, our sales outlook has been tempered by plant closures, suspensions in production and order deferrals and cancellations affecting our largest customers, Boeing and Airbus. Further, our commercial aerospace sales have been impacted by government-mandated shutdowns of 2 facilities in Mexico, creating some additional risks within our internal supply chain. As a result, we expect sales in this market to trend lower for the foreseeable future, particularly in the second quarter. Next, in power generation, within our nuclear aftermarket business, COVID-19 is impacting many U.S. nuclear plants. Social distancing measures are creating delays in equipment testing and resulting in a reduction in the scope of customer outages. There's also a growing risk of plant operators delaying capital projects to preserve liquidity, which is likely to impact our international aftermarket business. Elsewhere, revenues on the CAP1000 program have been generally unaffected to date. However, if this pandemic progresses late into the year, we may begin to experience delays in status checkpoints, which in turn could impact the timing of revenue recognition. In general industrial, we now expect reduced demand across all of our markets, which reflects our views for both market-specific drivers and weaker global economic activity. There are a few areas which I'd like to highlight. In industrial vehicles, where we were already forecasting softness in the on-highway market, we began to see production slowdowns and plant closures across the industry in March. We expect these trends to worsen in the second quarter and further impact our full year sales. In industrial valves, we expect reduced demand for the remainder of 2020 as the tremendous drop in oil and gas prices is likely to generate a pullback in industry capital expenditures on both oil and gas and chemical projects. Additionally, our MRO work, which represents about 70% of our mix in industrial valves has some risk due to delays in maintenance and turnarounds. However, it's worth noting that this market only represents about 4% of our annual sales. Next, the surface technologies, which maintains customer-facing facilities, principally in the U.S., China and Europe, we expect customer manufacturing to slow down in the second quarter and be down for the full year. Similar to our sales, we expect Curtiss-Wright's overall profitability to be challenged in 2020 as we manage through reduced volumes and under absorption within our commercial businesses. We are currently expecting the second quarter to be our weakest quarter as the disruption from COVID-19 is expected to drive significantly weakened demand. However, Curtiss-Wright is an agile and flexible business, and we have a strong track record to proactively driving margin improvement. Dave will cover the specific details of our cost containment actions in a few minutes. Next, to help you better understand Curtiss-Wright's potential downside risk, we're providing an estimate ranging from 25% to 30% for decremental margins on reduced sales. This is quite similar to our estimate of overall incremental margins. Regarding our restructuring activity communicated in February, we remain on track with those initiatives. When considering the cost containment actions that we're currently implementing in response to COVID-19, we believe there may be some upside to potentially exceed the $20 million in annualized savings that was originally projected. However, as this is an evolving situation, we're not in a position to provide new figures at this time. Turning to Slide 9. I'll focus on our balance sheet, where Curtiss-Wright is very well positioned with more than sufficient liquidity. Starting on the left-hand side of the slide, we concluded 2019 with a strong and healthy balance sheet, and we're well positioned for 2020. We have $750 million in private placement debt at an average interest rate of roughly 4%, with only one note maturing before 2023. In terms of our revolver status, we have a $500 million revolver and a $200 million accordion feature, which can be open for additional liquidity. As we've historically done, we started to borrow under the revolver in the first quarter, simply for general corporate purposes and not related to concerns about COVID-19. Thus far in 2020, we've executed $112 million in share repurchases, completed our acquisition at Dyna-Flo and made a voluntary contribution to the defined benefit pension plan. Our debt ratios remain well below any internally or externally driven limitations, where, for example, we have the ability to borrow $1.5 billion before approaching our debt covenants. Moving to the right-hand side of the slide. As a testament to our efficient capital structure, our operating leverage remains low. Our leverage ratio is at 1.7 times total debt-to-EBITDA and 1.4 times net debt-to-EBITDA are in line with a strong investment-grade rating. As you can see on the slide, we have conservatively averaged less than one times net debt-to-EBITDA over the past few years. In summary, Curtiss-Wright possesses a strong balance sheet and maintains a flexible, yet conservative capital structure providing further confidence that we can successfully navigate this downturn. Now I'd like to turn the call back over to Dave to continue with our prepared remarks. Dave?